XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Acquisition of FlexBiosys, Inc - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Apr. 17, 2023
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Business Acquisition [Line Items]        
Goodwill   $ 869,252 $ 869,252 $ 855,513
FlexBiosys        
Business Acquisition [Line Items]        
Business combination date of acquistion Apr. 17, 2023      
Equity consideration $ 41,000      
Cash consideration 29,000      
Business Combination, Indemnification Assets, Range of Outcomes, Value, High $ 6,300      
Shares of common stock issued for acquisition 31,415   31,415  
Value of common stock issued $ 41,000      
Business combination contingent consideration 6,600   $ 42,000  
Net liabilities assumed 14,100      
Business combination, intangible assets 12,600      
Intangible Asset Residual Value 14,300      
Business combination, acquisition related costs   500    
Transaction costs   900 900  
Goodwill   $ 14,321 $ 14,321  
FlexBiosys | Common Stock        
Business Acquisition [Line Items]        
Equity consideration 5,400      
Value of common stock issued $ 5,400